Clinical trial · Interventional
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia: A Randomized Prospective Comparison of Snares and Injectate in the Resection of Large Sessile Colonic Polyps
NCT01471756CI-TRIAL-00015558completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators seek to compare two techniques of removing pre-cancerous lesions from the colon. The investigators also will compare two solutions used during the procedure to determine if either solution allows for an improved removal of the tumors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Standard of Care Procedure as described in ARM | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- iSnare with Gonak solution
- interventionNames
- Procedure: Standard of Care Procedure as described in ARM
- type
- EXPERIMENTAL
- label
- Snaremaster braided snare with Gonak solution
- interventionNames
- Procedure: Standard of Care Procedure as described in ARM
- type
- EXPERIMENTAL
- label
- iSnare with saline solution
- interventionNames
- Procedure: Standard of Care Procedure as described in ARM
- type
- EXPERIMENTAL
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Sessile colorectal polyp * laterally spreading lesions as defined by Paris Classification type II and \> 1 cm or greater Exclusion Criteria: * Those with ulcerated depressed lesions (Paris type III) or biopsy proven invasive carcinoma * Inflammatory bowel disease patients * Coagulopathy ( INR\> 1.5) that cannot be corrected
References
Publications (0)
Data not yet available
No reference posted for this study.